{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:38:14Z","timestamp":1789738694680,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41388-018-0197-0","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T04:11:34Z","timestamp":1520309494000},"page":"3113-3130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["LMTK3 confers chemo-resistance in breast cancer"],"prefix":"10.1038","volume":"37","author":[{"given":"Justin","family":"Stebbing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpit","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei Cheng","family":"Lit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Ditsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Wendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-2716","authenticated-orcid":false,"given":"Thomas","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina S\u00e1ra","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"O\u2019Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-0631","authenticated-orcid":false,"given":"Michael","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April Camilla","family":"Roslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swee Hung","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Giamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"197_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nm.2351","volume":"17","author":"G Giamas","year":"2011","unstructured":"Giamas G, Filipovic A, Jacob J, Messier W, Zhang H, Yang D, et al. Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer. Nat Med. 2011;17:715\u20139.","journal-title":"Nat Med"},{"key":"197_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3892\/mco.2014.301","volume":"2","author":"Z Li","year":"2014","unstructured":"Li Z, Wu J, Ji M, Shi L, Xu B, Jiang J, et al. Prognostic role of lemur tyrosine kinase 3 in postoperative gastric cancer. Mol Clin Oncol. 2014;2:756\u201360.","journal-title":"Mol Clin Oncol"},{"key":"197_CR3","first-page":"1101","volume":"7","author":"H Shi","year":"2014","unstructured":"Shi H, Li Q, Ji M, Wu J, Li Z, Zheng X, et al. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer. Int J Clin Exp Pathol. 2014;7:1101\u20137.","journal-title":"Int J Clin Exp Pathol"},{"key":"197_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0754-x","volume":"30","author":"H Shi","year":"2013","unstructured":"Shi H, Wu J, Ji M, Zhou Q, Li Z, Zheng X, et al. Serum lemur tyrosine kinase 3 expression in colorectal cancer patients predicts cancer progression and prognosis. Med Oncol. 2013;30:754.","journal-title":"Med Oncol"},{"key":"197_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10549-011-1622-z","volume":"132","author":"J Stebbing","year":"2012","unstructured":"Stebbing J, Filipovic A, Ellis IO, Green AR, D\u2019Silva TR, Lenz HJ, et al. LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome. Breast Cancer Res Treat. 2012;132:537\u201344.","journal-title":"Breast Cancer Res Treat"},{"key":"197_CR6","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1073\/pnas.0903233106","volume":"106","author":"JW Tyner","year":"2009","unstructured":"Tyner JW, Deininger MW, Loriaux MM, Chang BH, Gotlib JR, Willis SG, et al. RNAi screen for rapid therapeutic target identification in leukemia patients. Proc Natl Acad Sci USA. 2009;106:8695\u20138700.","journal-title":"Proc Natl Acad Sci USA"},{"key":"197_CR7","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1158\/1535-7163.MCT-12-1134","volume":"12","author":"T Wakatsuki","year":"2013","unstructured":"Wakatsuki T, LaBonte MJ, Bohanes PO, Zhang W, Yang D, Azuma M, et al. Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States. Mol Cancer Ther. 2013;12:2261\u201372.","journal-title":"Mol Cancer Ther"},{"key":"197_CR8","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1007\/s13277-014-1660-3","volume":"35","author":"Z Xu","year":"2014","unstructured":"Xu Z, Qi X, Zhang X, Yu L. Preoperative serum LMTK3 as a novel biomarker in non-small cell lung cancer. Tumour Biol. 2014;35:5007\u201311.","journal-title":"Tumour Biol"},{"key":"197_CR9","first-page":"629","volume":"8","author":"K Zhang","year":"2015","unstructured":"Zhang K, Chen L, Deng H, Zou Y, Liu J, Shi H, et al. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression. Int J Clin Exp Pathol. 2015;8:629\u201335.","journal-title":"Int J Clin Exp Pathol"},{"key":"197_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14646","volume":"8","author":"C Gundry","year":"2017","unstructured":"Gundry C, Marco S, Rainero E, Miller B, Dornier E, Mitchell L, et al. Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-dependent EphA2 trafficking to promote cell:cell repulsion. Nat Commun. 2017;8:14646.","journal-title":"Nat Commun"},{"key":"197_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2015.12.026","volume":"372","author":"J Jacob","year":"2016","unstructured":"Jacob J, Favicchio R, Karimian N, Mehrabi M, Harding V, Castellano L, et al. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5. Cancer Lett. 2016;372:137\u201346.","journal-title":"Cancer Lett"},{"key":"197_CR12","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1038\/onc.2012.343","volume":"32","author":"J Stebbing","year":"2013","unstructured":"Stebbing J, Filipovic A, Lit LC, Blighe K, Grothey A, Xu Y, et al. LMTK3 is implicated in endocrine resistance via multiple signaling pathways. Oncogene. 2013;32:3371\u201380.","journal-title":"Oncogene"},{"key":"197_CR13","doi-asserted-by":"publisher","first-page":"ra58","DOI":"10.1126\/scisignal.2005170","volume":"7","author":"Y Xu","year":"2014","unstructured":"Xu Y, Zhang H, Lit LC, Grothey A, Athanasiadou M, Kiritsi M, et al. The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin beta(1). Sci Signal. 2014;7:ra58.","journal-title":"Sci Signal"},{"key":"197_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.celrep.2015.06.073","volume":"12","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zhang H, Nguyen VT, Angelopoulos N, Nunes J, Reid A, et al. LMTK3 represses tumor suppressor-like genes through chromatin remodeling in breast cancer. Cell Rep. 2015;12:837\u201349.","journal-title":"Cell Rep"},{"key":"197_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1089\/dna.2013.2130","volume":"32","author":"G Zhao","year":"2013","unstructured":"Zhao G, Guo J, Li D, Jia C, Yin W, Sun R, et al. MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line. DNA Cell Biol. 2013;32:699\u2013707.","journal-title":"DNA Cell Biol"},{"key":"197_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S1470-2045(16)00011-5","volume":"17","author":"F Bertucci","year":"2016","unstructured":"Bertucci F, Fekih M, Autret A, Petit T, Dalenc F, Levy C, et al. Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2016;17:600\u201311.","journal-title":"Lancet Oncol"},{"key":"197_CR17","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1200\/JCO.2014.55.9070","volume":"32","author":"AR Davies","year":"2014","unstructured":"Davies AR, Gossage JA, Zylstra J, Mattsson F, Lagergren J, Maisey N, et al. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol. 2014;32:2983\u201390.","journal-title":"J Clin Oncol"},{"key":"197_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/annonc\/mdx390.036","volume":"28","author":"M Yamasaki","year":"2017","unstructured":"Yamasaki M, Yasuda T, Yano M, Hirao M, Kobayashi K, Fujitani K, et al. Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003). Ann Oncol. 2017;28:116\u201320.","journal-title":"Ann Oncol"},{"key":"197_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.chembiol.2013.04.007","volume":"20","author":"K Cheung-Ong","year":"2013","unstructured":"Cheung-Ong K, Giaever G, Nislow C. DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. Chem Biol. 2013;20:648\u201359.","journal-title":"Chem Biol"},{"key":"197_CR20","first-page":"3248","volume":"17","author":"Y Pan","year":"2011","unstructured":"Pan Y, Gao Y, Chen L, Gao G, Dong H, Yang Y, et al. Targeting autophagy augments in vitro and in vivo antimyeloma activity of DNA-damaging chemotherapy. Clinical cancer research: an official journal of the American Association for. Cancer Res. 2011;17:3248\u201358.","journal-title":"Cancer Res"},{"key":"197_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56:185\u2013229.","journal-title":"Pharmacol Rev"},{"key":"197_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","volume":"21","author":"CF Thorn","year":"2011","unstructured":"Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, et al. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharm Genom. 2011;21:440\u20136.","journal-title":"Pharm Genom"},{"key":"197_CR23","first-page":"1512","volume":"3","author":"JL Nitiss","year":"2002","unstructured":"Nitiss JL. DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damage. Curr Opin Investig Drugs. 2002;3:1512\u20136.","journal-title":"Curr Opin Investig Drugs"},{"key":"197_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mrfmmm.2008.03.005","volume":"641","author":"DJ Smart","year":"2008","unstructured":"Smart DJ, Halicka HD, Schmuck G, Traganos F, Darzynkiewicz Z, Williams GM. Assessment of DNA double-strand breaks and gammaH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone. Mutat Res. 2008;641:43\u201347.","journal-title":"Mutat Res"},{"key":"197_CR25","doi-asserted-by":"publisher","first-page":"42462","DOI":"10.1074\/jbc.C100466200","volume":"276","author":"S Burma","year":"2001","unstructured":"Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem. 2001;276:42462\u20137.","journal-title":"J Biol Chem"},{"key":"197_CR26","doi-asserted-by":"publisher","first-page":"53272","DOI":"10.1074\/jbc.M406879200","volume":"279","author":"EU Kurz","year":"2004","unstructured":"Kurz EU, Douglas P, Lees-Miller SP. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J Biol Chem. 2004;279:53272\u201381.","journal-title":"J Biol Chem"},{"key":"197_CR27","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1074\/jbc.M606306200","volume":"282","author":"YK Lee","year":"2007","unstructured":"Lee YK, Thomas SN, Yang AJ, Ann DK. Doxorubicin down-regulates Kruppel-associated box domain-associated protein 1 sumoylation that relieves its transcription repression on p21WAF1\/CIP1 in breast cancer MCF-7 cells. J Biol Chem. 2007;282:1595\u2013606.","journal-title":"J Biol Chem"},{"key":"197_CR28","doi-asserted-by":"publisher","first-page":"36177","DOI":"10.1074\/jbc.M706912200","volume":"282","author":"X Li","year":"2007","unstructured":"Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, et al. Role for KAP1 serine 824 phosphorylation and sumoylation\/desumoylation switch in regulating KAP1-mediated transcriptional repression. J Biol Chem. 2007;282:36177\u201389.","journal-title":"J Biol Chem"},{"key":"197_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccr.2006.11.024","volume":"11","author":"HC Reinhardt","year":"2007","unstructured":"Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK\/MK2 pathway for survival after DNA damage. Cancer Cell. 2007;11:175\u201389.","journal-title":"Cancer Cell"},{"key":"197_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421:499\u2013506.","journal-title":"Nature"},{"key":"197_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1083\/jcb.200906064","volume":"187","author":"S So","year":"2009","unstructured":"So S, Davis AJ, Chen DJ. Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites. J Cell Biol. 2009;187:977\u201390.","journal-title":"J Cell Biol"},{"key":"197_CR32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.18632\/oncoscience.162","volume":"2","author":"CJ Bakkenist","year":"2015","unstructured":"Bakkenist CJ, Czambel RK, Hershberger PA, Tawbi H, Beumer JH, Schmitz JC. A quasi-quantitative dual multiplexed immunoblot method to simultaneously analyze ATM and H2AX Phosphorylation in human peripheral blood mononuclear cells. Oncoscience. 2015;2:542\u201354.","journal-title":"Oncoscience"},{"key":"197_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3892\/ijo.2012.1680","volume":"42","author":"G Brum","year":"2013","unstructured":"Brum G, Carbone T, Still E, Correia V, Szulak K, Calianese D, et al. N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells. Int J Oncol. 2013;42:211\u20138.","journal-title":"Int J Oncol"},{"key":"197_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3858\/emm.2008.40.3.276","volume":"40","author":"EJ Jung","year":"2008","unstructured":"Jung EJ, Kim CW, Kim DR. Cytosolic accumulation of gammaH2AX is associated with tropomyosin-related kinase A-induced cell death in U2OS cells. Exp Mol Med. 2008;40:276\u201385.","journal-title":"Exp Mol Med"},{"key":"197_CR35","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858\u201368.","journal-title":"J Biol Chem"},{"key":"197_CR36","doi-asserted-by":"publisher","first-page":"20303","DOI":"10.1074\/jbc.M300198200","volume":"278","author":"T Furuta","year":"2003","unstructured":"Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, Sedelnikova OA, et al. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem. 2003;278:20303\u201312.","journal-title":"J Biol Chem"},{"key":"197_CR37","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1158\/0008-5472.CAN-03-3207","volume":"64","author":"T Stiff","year":"2004","unstructured":"Stiff T, O\u2019Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 2004;64:2390\u20136.","journal-title":"Cancer Res"},{"key":"197_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1083\/jcb.146.5.905","volume":"146","author":"EP Rogakou","year":"1999","unstructured":"Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol. 1999;146:905\u201316.","journal-title":"J Cell Biol"},{"key":"197_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4:359\u201365.","journal-title":"Nat Methods"},{"key":"197_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10911-004-1402-z","volume":"9","author":"KR Shaw","year":"2004","unstructured":"Shaw KR, Wrobel CN, Brugge JS. Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis. J Mammary Gland Biol Neoplas. 2004;9:297\u2013310.","journal-title":"J Mammary Gland Biol Neoplas"},{"key":"197_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-62703-125-7_13","volume":"945","author":"PA Vidi","year":"2013","unstructured":"Vidi PA, Bissell MJ, Lelievre SA. Three-dimensional culture of human breast epithelial cells: the how and the why. Methods Mol Biol. 2013;945:193\u2013219.","journal-title":"Methods Mol Biol"},{"key":"197_CR42","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.1021\/jacs.5b00922","volume":"137","author":"ZH Peng","year":"2015","unstructured":"Peng ZH, Kopecek J. Enhancing accumulation and penetration of HPMA copolymer-doxorubicin conjugates in 2D and 3D prostate cancer cells via iRGD conjugation with an MMP-2 cleavable spacer. J Am Chem Soc. 2015;137:6726\u20139.","journal-title":"J Am Chem Soc"},{"key":"197_CR43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.7150\/thno.6381","volume":"3","author":"LK Senavirathna","year":"2013","unstructured":"Senavirathna LK, Fernando R, Maples D, Zheng Y, Polf JC, Ranjan A. Tumor Spheroids as an in vitro model for determining the therapeutic response to proton beam radiotherapy and thermally sensitive nanocarriers. Theranostics. 2013;3:687\u201391.","journal-title":"Theranostics"},{"key":"197_CR44","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1016\/j.biomaterials.2013.03.008","volume":"34","author":"X Wang","year":"2013","unstructured":"Wang X, Zhen X, Wang J, Zhang J, Wu W, Jiang X. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles. Biomaterials. 2013;34:4667\u201379.","journal-title":"Biomaterials"},{"key":"197_CR45","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1534-5807(03)00093-5","volume":"4","author":"O Fernandez-Capetillo","year":"2003","unstructured":"Fernandez-Capetillo O, Mahadevaiah SK, Celeste A, Romanienko PJ, Camerini-Otero RD, Bonner WM, et al. H2AX is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. Dev Cell. 2003;4:497\u2013508.","journal-title":"Dev Cell"},{"key":"197_CR46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1385\/MB:26:3:249","volume":"26","author":"AR Collins","year":"2004","unstructured":"Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol. 2004;26:249\u201361.","journal-title":"Mol Biotechnol"},{"key":"197_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive PL, Banath JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc. 2006;1:23\u201329.","journal-title":"Nat Protoc"},{"key":"197_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/FPC.0b013e32831ebb5d","volume":"19","author":"SC Lee","year":"2009","unstructured":"Lee SC, Xu X, Lim YW, Iau P, Sukri N, Lim SE, et al. Chemotherapy-induced tumor gene expression changes in human breast cancers. Pharm Genom. 2009;19:181\u201392.","journal-title":"Pharm Genom"},{"key":"197_CR49","first-page":"84","volume":"1845","author":"F Yang","year":"2014","unstructured":"Yang F, Teves SS, Kemp CJ, Henikoff S. Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Et Biophys Acta. 2014;1845:84\u201389.","journal-title":"Biochim Et Biophys Acta"},{"key":"197_CR50","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1038\/sj.onc.1208627","volume":"24","author":"YW Eom","year":"2005","unstructured":"Eom YW, Kim MA, Park SS, Goo MJ, Kwon HJ, Sohn S, et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene. 2005;24:4765\u201377.","journal-title":"Oncogene"},{"key":"197_CR51","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S1470-2045(14)70080-4","volume":"15","author":"L Gianni","year":"2014","unstructured":"Gianni L, Eiermann W, Semiglazov V, Lluch A, Tjulandin S, Zambetti M, et al. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet Oncol. 2014;15:640\u20137.","journal-title":"Lancet Oncol"},{"key":"197_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/1078-0432.CCR-14-3304","volume":"22","author":"C Hatzis","year":"2016","unstructured":"Hatzis C, Symmans WF, Zhang Y, Gould RE, Moulder SL, Hunt KK. et al.Relationship between complete pathologic response to neoadjuvant chemotherapy and survival in triple-negative breast cancer. Clin Cancer Res. 2016;22:26\u201333.","journal-title":"Clin Cancer Res"},{"key":"197_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2016.05.015","volume":"64","author":"G Minckwitz von","year":"2016","unstructured":"von Minckwitz G, Rezai M, Tesch H, Huober J, Gerber B, Zahm DM, et al. Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36\/ABCSG 29). Eur J Cancer. 2016;64:12\u201321.","journal-title":"Eur J Cancer"},{"key":"197_CR54","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1158\/1078-0432.CCR-12-2986","volume":"19","author":"KD Yu","year":"2013","unstructured":"Yu KD, Zhu R, Zhan M, Rodriguez AA, Yang W, Wong S. et al.Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer. Clin Cancer Res. 2013;19:2723\u201333.","journal-title":"Clin Cancer Res"},{"key":"197_CR55","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008;8:957\u201367.","journal-title":"Nat Rev Cancer"},{"key":"197_CR56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fgene.2014.00288","volume":"5","author":"A Azqueta","year":"2014","unstructured":"Azqueta A, Slyskova J, Langie SA, O\u2019Neill Gaivao I, Collins A. Comet assay to measure DNA repair: approach and applications. Front Genet. 2014;5:288.","journal-title":"Front Genet"},{"key":"197_CR57","doi-asserted-by":"publisher","first-page":"11594","DOI":"10.1158\/0008-5472.CAN-06-4138","volume":"66","author":"DE White","year":"2006","unstructured":"White DE, Negorev D, Peng H, Ivanov AV, Maul GG, Rauscher FJ 3rd. KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions. Cancer Res. 2006;66:11594\u20139.","journal-title":"Cancer Res"},{"key":"197_CR58","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ncb1446","volume":"8","author":"Y Ziv","year":"2006","unstructured":"Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, Schultz DC, et al. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat Cell Biol. 2006;8:870\u20136.","journal-title":"Nat Cell Biol"},{"key":"197_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-196","volume":"12","author":"H Li","year":"2014","unstructured":"Li H, Zheng D, Zhang B, Liu L, Ou J, Chen W, et al. Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cellcarcinoma. J Transl Med. 2014;12:196.","journal-title":"J Transl Med"},{"key":"197_CR60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.bjc.6605486","volume":"102","author":"J Chen","year":"2010","unstructured":"Chen J, Imanaka N, Chen J, Griffin JD. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer. 2010;102:351\u201360.","journal-title":"Br J Cancer"},{"key":"197_CR61","doi-asserted-by":"publisher","first-page":"27599","DOI":"10.18632\/oncotarget.8504","volume":"7","author":"J Nunes","year":"2016","unstructured":"Nunes J, Zhang H, Angelopoulos N, Chhetri J, Osipo C, Grothey A, et al. ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation. Oncotarget. 2016;7:27599\u2013612.","journal-title":"Oncotarget"},{"key":"197_CR62","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1042\/BJ20070091","volume":"406","author":"G Giamas","year":"2007","unstructured":"Giamas G, Hirner H, Shoshiashvili L, Grothey A, Gessert S, Kuhl M, et al. Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo. Biochem J. 2007;406:389\u201398.","journal-title":"Biochem J"},{"key":"197_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.redox.2013.12.020","volume":"2","author":"BM Gyori","year":"2014","unstructured":"Gyori BM, Venkatachalam G, Thiagarajan PS, Hsu D, Clement MV. OpenComet: an automated tool for comet assay image analysis. Redox Biol. 2014;2:457\u201365.","journal-title":"Redox Biol"},{"key":"197_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"197_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"197_CR66","doi-asserted-by":"crossref","first-page":"14233","DOI":"10.18632\/oncotarget.3899","volume":"6","author":"K Shah","year":"2015","unstructured":"Shah K, Bradbury NA. Lemur tyrosine kinase 2, a novel target in prostate cancer therapy. Oncotarget. 2015;6:14233\u201346.","journal-title":"Oncotarget"},{"key":"197_CR67","doi-asserted-by":"publisher","first-page":"D1130","DOI":"10.1093\/nar\/gks1253","volume":"41","author":"X Lucas","year":"2013","unstructured":"Lucas X, Senger C, Erxleben A, Gruning BA, Doring K, Mosch J, et al. StreptomeDB: a resource for natural compounds isolated from Streptomyces species. Nucleic Acids Res. 2013;41:D1130\u20136.","journal-title":"Nucleic Acids Res"},{"key":"197_CR68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25\u201329.","journal-title":"Nat Genet"},{"key":"197_CR69","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","volume":"45","author":"The Gene Ontology C.","year":"2017","unstructured":"The Gene Ontology C. Expansion of the gene ontology knowledgebase and resources. Nucleic Acids Res. 2017;45:D331\u20138.","journal-title":"Nucleic Acids Res"},{"key":"197_CR70","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRINGv10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447\u201352.","journal-title":"Nucleic Acids Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0197-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0197-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0197-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:10:48Z","timestamp":1684602648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0197-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":70,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0197-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"27 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JS is Editor of\n                      Oncogene\n                      , GG is a Deputy Editor. This manuscript went through a standard external peer review process and neither were involved with this. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}